Marinus Pharmaceuticals Funding: $21M Raised, Series C
Marinus Pharmaceuticals has raised $21M in total funding. Latest round: Series C. Backed by Domain Associates, Rusnano MedInvest, Canaan Partners.
Marinus Pharmaceuticals funding overview
Marinus Pharmaceuticals has raised $21M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series C announced in January 2013. The round record for Marinus Pharmaceuticals runs through 2013; nothing later has been disclosed. Investors on record include Domain Associates, Rusnano MedInvest, Canaan Partners, Sofinnova Ventures, Foundation Medical Partners. 5 distinct backers are named across the disclosed rounds.
Marinus Pharmaceuticals at a glance
Total raised
$21M
Latest round
Series C
Latest round date
January 2013
Notable investors
Domain Associates, Rusnano MedInvest, Canaan Partners, Sofinnova Ventures, Foundation Medical Partners
Frequently asked about Marinus Pharmaceuticals funding
How much has Marinus Pharmaceuticals raised?
Marinus Pharmaceuticals has raised $21M in total disclosed funding across the rounds on record.
Who has invested in Marinus Pharmaceuticals?
Domain Associates, Rusnano MedInvest, Canaan Partners, Sofinnova Ventures, Foundation Medical Partners are named among the investors backing Marinus Pharmaceuticals.
What was the latest Marinus Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in January 2013.
Where is Marinus Pharmaceuticals based?
No headquarters location is disclosed for Marinus Pharmaceuticals.
When did Marinus Pharmaceuticals last raise?
The last disclosed Marinus Pharmaceuticals round closed in January 2013 at Series C.
Totals shown for Marinus Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
